2,3-Dichloro-5,6-dicyano-1,4-benzoquinone → HCID 10023954, compound

HRID 1826805Notes

Reaction equation

HRID 1826805 reaction equation
Cl.FC(C1C=CC=CC=1C1(NC2C=C3C(=CC=2)NC(=O)CC3)C=CN=CN1)(F)F.[Cl:30]C1C(=O)C(C#N)=C(C#N)C(=O)C=1Cl.C[Si](N([Si](C)(C)C)C(=O)C(F)(F)F)(C)C.CO[C:61]1[CH:70]=[CH:69][C:68]2[C:63](=[CH:64][C:65]([NH:71][C:72]3[CH:77]=[C:76]([C:78]4[CH:83]=[CH:82][C:81]([C:84]([F:87])([F:86])[F:85])=[CH:80][CH:79]=4)[N:75]=[CH:74][N:73]=3)=[CH:66][CH:67]=2)[N:62]=1>O1CCOCC1>[Cl:30][C:61]1[CH:70]=[CH:69][C:68]2[C:63](=[CH:64][C:65]([NH:71][C:72]3[CH:77]=[C:76]([C:78]4[CH:83]=[CH:82][C:81]([C:84]([F:87])([F:86])[F:85])=[CH:80][CH:79]=4)[N:75]=[CH:74][N:73]=3)=[CH:66][CH:67]=2)[N:62]=1

Participants

6

Conditions

Temperature
25 °C

Procedure

7-[6-(4-(Trifluoromethylphenyl)pyrimidin-4-ylamino]-3,4-dihydro-1H-quinolin-2-one hydrochloride, Example 9(c), (500 mg, 1.2 mmol) was suspended in anhydrous 1,4-dioxane (10 mL), under N2, in a flame-dried, round-bottomed flask equipped with a reflux condenser. The suspension was magnetically stirred at 25° C. and treated with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (350 mg, 1.5 mmol, Aldrich) followed by bis(trimethylsilyl)trifluoroacetamide (1.4 mL, 5.3 mmol, Aldrich). The reaction mixture was stirred in a 105° C. oil bath for 15 min, then allowed to cool to 25° C. and partitioned between EtOAc (150 mL) and 1% aq NaHSO3 (100 mL). The resulting emulsion was allowed to settle, and the organic phase was separated and concentrated in vacuo to a brown solid (1.1 g). The solid was treated with phosphorous oxychloride (10 mL, Aldrich) and stirred in a 100° C. oil bath for 1 h. After cooling to room temp, the reaction was quenched by slow addition to MeOH (200 mL), then concentrated in vacuo. The residue was treated with a mixture of 30% NH4OH and ice (200 mL), then extracted with EtOAc (2×100 mL). The combined organic extract was washed with satd NaCl (50 mL), dried over Na2SO4, filtered and concentrated in vacuo. Purification by silica gel chromatography (30% EtOAc in hexane) provided a mixture of the title product and (2-methoxyquinolin-7-yl)-[6-(4-trifluoromethylphenyl)pyrimidin-4-yl]amine (Example 12), and the pure title product as a white solid. MS (ESI, pos. ion) m/z: 401 (M+1). MP: 233° C.

Workup

  1. customequipped with a reflux condenser
  2. stirringThe reaction mixture was stirred in a 105° C. oil bath for 15 min
  3. temperatureto cool to 25° C.
  4. custompartitioned between EtOAc (150 mL) and 1% aq NaHSO3 (100 mL)
  5. customthe organic phase was separated
  6. concentrationconcentrated in vacuo to a brown solid (1.1 g)
  7. additionThe solid was treated with phosphorous oxychloride (10 mL, Aldrich)
  8. stirringstirred in a 100° C. oil bath for 1 h
  9. temperatureAfter cooling to room temp
  10. customthe reaction was quenched by slow addition to MeOH (200 mL)
  11. concentrationconcentrated in vacuo
  12. additionThe residue was treated with a mixture of 30% NH4OH and ice (200 mL)
  13. extractionextracted with EtOAc (2×100 mL)
  14. extractionThe combined organic extract
  15. washwas washed with satd NaCl (50 mL)
  16. dry with materialdried over Na2SO4
  17. filtrationfiltered
  18. concentrationconcentrated in vacuo
  19. customPurification by silica gel chromatography (30% EtOAc in hexane)
  20. customprovided

Sources & evidence

ORD record
ord-8bfa6cefe71c476b8e05a7c142377d60
Source dataset
uspto-grants-2006_05
Patent number
US07053088B2

Reaction notes

Loading…